FME:ETR
Fresenius Medical Care AG
40,82 €
arrow_upward
+0,25%(+0,100) 1D
11-ноя., 17:09:37 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FME...
Open
40,96 €
High
41,22 €
Low
40,54 €
Mkt. cap
10,96 млд
Avg. vol.
1,01 млн
Volume
304,63 миң
Dividend
3,65%
Quarterly dividend
0,37 €
Ex-dividend date
2026-ж., 22-май
P/E ratio
13,64
52-wk high
45,90 €
52-wk low
34,57 €
EPS
2,99 €
Shares outstanding
268,56 млн
No. of employees
106 миң
Open
40,96 €
High
41,22 €
Low
40,54 €
Mkt. cap
10,96 млд
Avg. vol.
1,01 млн
Volume
304,63 миң
Dividend
3,65%
Quarterly dividend
0,37 €
Ex-dividend date
2026-ж., 22-май
P/E ratio
13,64
52-wk high
45,90 €
52-wk low
34,57 €
EPS
2,99 €
Shares outstanding
268,56 млн
No. of employees
106 миң
News stories
From web sources and news partners
Yahoo Finance
·
2 күн мурун
Barclays sees Fresenius Medical Care earnings hit by reimbursement pressures
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees106 миң
Founded1996
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitefreseniusmedicalcare.com